All Dealmakers
Similar Dealmakers
Partner at Paul Weiss Rifkind Wharton & Garrison
Lawyer
New York
Deal Bio
Market Context
Back to top
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (48)
Key Relationships
Sort
Linde
Praxair
£56.94b
dealmakers
Whole Foods Market
Amazon.com
£10.75b
Western Refining Logistics
Andeavor Logistics
value n/a
Cascadian Therapeutics
Seattle Genetics
£435m
Xerox Corporation
Fujifilm Holdings Corp
£6.10b
Linde (american Businesses)
Cvc Capital Partners
£2.70b
Genesis Robotics
Koch Industries
Forest City Realty Trust
Brookfield Asset Management
£8.69b
Syntimmune
Alexion Pharmaceuticals
£1.07b
Biohaven Pharmaceutical Holding Company
Royalty Pharma
Cheniere Energy Partners Holdings
Cheniere Energy
Lasalle Hotel Properties
Blackstone Group
Rsp Permian
Concho Resources
£6.69b
General Cable Corporation
Prysmian
Inventiv Health
Research Holdings
Nightstar Therapeutics
Biogen
£663m
SYNTHORX
Sanofi
£1.90b
Unisys (us Federal Business)
Science Applications International Corporation
£921m
John Varvatos Enterprises
Lion Capital
MYOKARDIA
Bristol Myers Squibb Company
£10.01b
Conocophillips Company
£7.51b
NATROL
New Mountain Capital
£421m
Precision Medicine Group
£1.73b
Pra Health Sciences
Icon
£8.52b
Qad
Thoma Bravo
£1.44b
Veoneer
Qualcomm
£3.23b
Translate Bio
£2.30b
General Electric (healthcare)
Institutional Investors
FLUIDIGM
Casdin Capital
£184m
John Wood Group (environment Consulting Division)
Wsp Global
£1.51b
One Medical Group
£3.25b
Irobot Corp
£1.40b
Logicbio Therapeutics
£60m
Tom Ford
Estee Lauder Companies
£2.38b
Albireo Pharma
IPSEN
£786m
Sphere Entertainment Co
Bellus Health
Glaxosmithkline
£1.61b
Amedisys
Optum
£2.66b
Baker Hill
Flexpoint Ford
COINDESK
BULLISH
Manchester United
Jim Ratcliffe
£1.23b
Two Bitcoin Mining Sites
Marathon Digital
£140m
Endeavor Energy Resources
Diamondback Energy
£20.58b
Landos Biopharma
Abbvie
£168m
INHIBRX
£1.34b
Elsie Biotechnologies
£39m
Enstar Group
Sixth Street Partners
£3.96b
Community Oncology Revitalization Enterprise Ventures
Mckesson Corporation
£1.88b